Authors/Disclosures
|
Ethan M. Goldberg, MD, PhD
(The Children's Hospital of Philadelphia)
|
Dr. Goldberg has nothing to disclose. |
|
Peter Turkeltaub, MD, PhD
(Georgetown University)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Colin Quinn, MD
(University of Pennsylvania)
|
Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx Pharmaceuticals. Dr. Quinn has received personal compensation in the range of $0-$499 for serving as a Consultant for Amicus. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta Therapeutics. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Quinn has received personal compensation in the range of $0-$499 for serving as a Consultant for Clene Nanomedicine. Dr. Quinn has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Partners Health Care. Dr. Quinn has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Robins Kaplan. |
|
Amer Malik, MD
(University of Miami Miller School of Medicine)
|
Dr. Malik has nothing to disclose. |
|
Charles R. Cantor, MD
|
No disclosure on file |
|
|
No disclosure on file |
|
Harry B. Coslett, MD, FAAN
(Univ of Pennsylvania)
|
The institution of Dr. Coslett has received research support from NIDCD, NINDS, NIA. Dr. Coslett has received publishing royalties from a publication relating to health care. |